Cargando…
Expression of CYLD and NF-κB in Human Cholesteatoma Epithelium
The tumor suppressor CYLD is a deubiquitinating enzyme that inhibits activation of the NF-κB, which has key roles in inflammation and apoptosis. We hypothesized that CYLD may regulate the NF-κB signaling pathway in cholesteatoma. We conducted immunohistochemistry to examine the expression of CYLD an...
Autores principales: | Byun, Jae Yong, Yune, Tae Young, Lee, Jee Youn, Yeo, Seung Geun, Park, Moon Suh |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2858283/ https://www.ncbi.nlm.nih.gov/pubmed/20414373 http://dx.doi.org/10.1155/2010/796315 |
Ejemplares similares
-
Relationship between clinicopathological characteristics and CYLD expression in patients with cholesteatoma
por: Miyake, Shunsuke, et al.
Publicado: (2020) -
Optineurin Is Required for CYLD-Dependent Inhibition of TNFα-Induced NF-κB Activation
por: Nagabhushana, Ananthamurthy, et al.
Publicado: (2011) -
CYLD Deubiquitinase Negatively Regulates High Glucose-Induced NF-κB Inflammatory Signaling in Mesangial Cells
por: Li, Yanhui, et al.
Publicado: (2017) -
Downregulation of LEF1 Impairs Myeloma Cell Growth Through Modulating CYLD/NF-κB Signaling
por: Zhang, Guihua, et al.
Publicado: (2021) -
Clinical Differences in Types of Otalgia
por: Kim, Sang Hoon, et al.
Publicado: (2015)